GC MS Receives Export Approval for '10-Minute COVID-19 Diagnostic Kit' View original image


[Asia Economy, reporter Cho Hyun] GC MS announced on August 31 that it had received export approval from the Ministry of Food and Drug Safety on August 28 for its point-of-care testing (POCT) antigen diagnostic kit for COVID-19, ‘GENEDIA W COVID-19 Ag’.


This product is an antigen diagnostic kit that uses antigen-antibody binding reactions to diagnose COVID-19 infection on-site within 10 minutes. Using nasopharyngeal and sputum samples, it allows for visual confirmation of early-stage COVID-19 infection without any additional equipment.


With this approval, GC MS can now export a total of five products: two types of antibody diagnostic kits, two types of molecular diagnostic kits, and now an antigen diagnostic kit.



GC MS CEO Ahn Eunok stated, "We plan to build an integrated diagnostic platform for COVID-19 by adding fluorescent immunoassay products in the future."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing